Seeking Alpha

BMO starts Ironwood at Market Perform

  • Not everyone is overly concerned with downside to Linzess estimates, despite downbeat commentary from Goldman and Mizuho.
  • BMO initiates Ironwood Pharmaceuticals (IRWD) at Market Perform.
  • Price target is $15, well above Goldman's $9.50 objective.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector